Synonym: 2,3,5-Trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-D-erythro-pentonamide sulfate hydrate; Crixivan hydrate; L-735,524 hydrate; MK-639 hydrate
Empirical Formula (Hill Notation): C36H47N5O4·H2SO4 · xH2O
Molecular Weight: 711.87 (anhydrous basis)
Linear Formula: C36H47N5O4·H2SO4 · xH2O
Product Type: Chemical
assay |
≥98% (HPLC) |
color |
white to tan |
form |
powder |
originator |
Merck & Co., Inc., Kenilworth, NJ, U.S. |
Quality Level |
100 |
solubility |
H2O: ≥15 mg/mL |
storage condition |
desiccated |
storage temp. |
2-8°C |
Application: |
Indinavir sulfate salt hydrate may be used in HIV-related cell signaling studies. |
Biochem/physiol Actions: |
Indinavir sulfate is an antiviral HIV protease inhibitor. |
Biochem/physiol Actions: |
Indinavir sulfate suppresses the replication of HIV and is an important component of antiretroviral therapy for initial treatment of HIV infection. It is known to cause renal and urologic toxicity. |
Features and Benefits: |
This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S. . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
Packaging: |
10, 50 mg in glass bottle |
RIDADR |
NONH for all modes of transport |
WGK Germany |
WGK 3 |
Flash Point(F) |
Not applicable |
Flash Point(C) |
Not applicable |
Purity |
≥98% (HPLC) |
Storage Temp. |
2-8°C |
UNSPSC |
12352200 |